Lunai Bioworks Inc.
LNAI
$1.02
-$0.15-12.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.29% | -2.95% | |||
| Depreciation & Amortization | 1.88% | -0.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.17% | -8.44% | |||
| Operating Income | 1.17% | 8.44% | |||
| Income Before Tax | -67,083.19% | 102.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -67,083.19% | 102.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -67,083.19% | 102.61% | |||
| EBIT | 1.17% | 8.44% | |||
| EBITDA | 1.19% | 8.50% | |||
| EPS Basic | -61,604.27% | 102.61% | |||
| Normalized Basic EPS | 9.01% | 7.00% | |||
| EPS Diluted | -62,673.91% | 102.57% | |||
| Normalized Diluted EPS | 8.14% | 7.88% | |||
| Average Basic Shares Outstanding | 8.49% | 0.32% | |||
| Average Diluted Shares Outstanding | 7.43% | 1.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||